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Abstract: In recent years, extracellular vesicles (EVs) have become a subject of intense study.
These membrane-enclosed spherical structures are secreted by almost every cell type and are engaged
in the transport of cellular content (cargo) from parental to target cells. The impact of EVs transfer
has been observed in many vital cellular processes including cell-to-cell communication and immune
response modulation; thus, a fast and precise characterization of EVs may be relevant for both
scientific and diagnostic purposes. In this review, the most popular analytical techniques used in EVs
studies are presented with the emphasis on exosomes and microvesicles characterization.
Keywords: extracellular vesicles (EVs); exosomes; microvesicles (MVs); flow cytometry; dynamic
light scattering (DLS); stimulated emission depletion microscopy (STED); nanoparticle tracking
analysis (NTA); transmission electron microscopy (TEM); cryo-electron microscopy (Cryo-EM);
atomic force microscopy (AFM)
1. Extracellular Vesicles
Extracellular vesicles (EVs) are defined as membrane fragments released during the lifespan of
a vast majority of cells. These vesicles are surrounded by a phospholipid bilayer, whose composition
is very similar to the cell of origin. EVs carry a large repertoire of molecules including proteins
(e.g., cytokines, receptors, or their ligands), nucleic acids (DNA, mRNA, and miRNA), and lipids.
The lumen of EVs forms a perfect environment for biologically active components [1]. Transport in
the bloodstream of signaling molecules such as hormones is not problematic, but it becomes almost
impossible in the case of highly-degradable molecules such as nucleic acids. The lipid bilayer of
EVs protects these molecules from degradation in the extracellular milieu, and thus allows their
“safe” delivery to the target cell. For example, the delivery of miRNA by exosomes enables very fast
alterations of gene expression in the targeted cells [2].
The EVs molecular composition, defined by both the inside cargo and the components present
in the vesicles’ membrane, presumes their functions [3–5]. Although, EVs content reproduces the
properties and status of the parental cell, the protein and nucleic acid composition indicates the
involvement of specific, yet still unknown, mechanisms leading to their release. Initially, it was thought
that the EVs release is due to disposal of superfluous or harmful content [4], however, the accumulated
evidence shows that, most probably, the role of EVs is to emit signaling and regulatory molecules [4–6].
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The specific molecular composition enables them to be recognized by, or transferred to, other cells.
In that manner they can influence the phenotype and function of the recipient cell. The interaction with
other cells can proceed through different mechanisms, including specific ligand-receptor interactions
activating intracellular pathways or internalization by the recipient cells through membrane fusion or
via endocytosis/phagocytosis with the subsequent transfer and release of EVs cargo [2,7]. With the
discovery of miRNA transported by exosomes, the growing evidence links a specific miRNA pattern
present in blood serum with a certain type of cancer [7,8].
The adopted EVs classification system [9] divides these membrane structures into three groups:
exosomes, ectosomes (referred here as microvesicles, MVs), and apoptotic bodies (Figure 1). It should
be pointed out that each individual cell is capable of releasing both exosomes and MVs simultaneously.
Their presence can be detected in all body fluids (such as blood, lymph, saliva, urine, cerebrospinal
fluids, breast milk, and pleural effusions of ascites) at high levels: one microliter of blood serum may
contain over 3 million vesicles [10–12].
Figure 1. The extracellular vesicles (EVs) release. Alive cells release both exosomes and microvesicles
either constitutively and/or under activation. Exosomes are formed from multivesicular bodies while
microvesicles arise through direct budding from the plasma membrane. The cells undergoing apoptosis
release apoptotic bodies formed by random blebbing.
Exosomes have been identified to be released from multivesicular bodies during their fusion with
the plasma membrane. They are small vesicles characterized by a diameter range of 40–100 nm and
by a density of 1.13–1.19 g/cm2 [13–15]. They can be identified by specific markers indicating their
endocytic origin, such as ALG-2-interacting protein X (Alix), tumor susceptibility gene 101 (TSG101),
and tetraspanins [16], however, today a combination of these markers is preferred.
Microvesicles (MVs) are shed from the plasma membrane through direct outward budding of
the plasma membrane, which defines their diameter and molecular composition [12,17]. The MVs
size varies between 100 to 1000 nm [12,18]. They are released to the extracellular milieu after a
selective incorporation of proteins, nucleic acids and lipids, and thus they are more heterogeneous
than exosomes bearing surface markers such as integrins or selectins. The expression level of these
markers reflects the properties of the parental cells [16,19]. Unlike exosomes, there is no specific marker
defining MVs.
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Apoptotic bodies are released upon cell fragmentation during late phase of apoptosis. Their
diameter varies from 50 to 5000 nm [18]. This type of EVs can be identified by the detection of DNA
and histones.
Since EVs are shed during cell growth, activation, proliferation, senescence, and apoptosis by
different cell types, their ability to transfer functional cargo is an important factor in cell-to-cell
communication, immune responses, signaling cascades, etc. [20–23]. In particular, MVs and exosomes
are considered to be novel mediators of cell-to-cell communication that play an important role in both
physiological and pathological processes. Therefore, it is of great interest not only to develop reliable
isolation protocols but also to study their molecular, biochemical and biophysical properties [17,24,25].
The biological importance of EVs is emphasized by the fact that their cargo possesses a significant
regulatory potential. Acting as conveyors of information, they can deliver their cargo to specific distant
targets [10,26]. Messages convoyed by vesicles include signals crucial for cellular division, survival,
differentiation, response to stress, and apoptosis [2,27]. In the last few years, many groups have
investigated EVs potential as valuable biomarkers of pathological processes, including cancer [7,28–30].
The ability of EVs to carry information on the physiological state of the cell of origin is a driving
force for the adaptation/development of various techniques enabling the detection and characterization
of their molecular, biochemical, and biophysical properties. Some of these features, such as size,
morphology, concentration, cellular origin and molecular composition, can be utilized for EVs
characterization. The advancement of new technologies will certainly impose changes in the techniques
used for EVs research, however, this will require some time. In this review, the most common and most
accessible EVs research techniques are discussed, with the emphasis on exosomes and mircovesicles.
Table 1 enlists the most widely used techniques in EVs studies.
Table 1. The most common techniques used in the studies of the EVs.
Technique What Is Measured Information Acquired
Flow cytometry Scattered and fluorescent lights Particles’ * phenotype, absolutenumber and size (with limitations)
Dynamic light scattering (DLS) Intensity of scattered light asa function of time
Particles’ size typically in the
submicron scale, size distribution
Nanoparticle tracking
analysis (NTA) Scattered light






Scattered electron beam Morphology, particles’ size
Atomic force microscopy (AFM) Interaction forces between theprobing tip and surface
Particles’ three-dimensional
(3D)topography, diameter
* For clarity, the word “particles” here refers to EVs.
2. Flow Cytometry and Related Methods
Over the last two decades, flow cytometry has been regarded as one of the most commonly used
techniques for EVs analysis, with the ability to determine the cellular origin of single EVs. Although
having limitations in detecting small EVs, namely exosomes, this method enables the analysis of
thousands of EVs in one sample, with a simultaneous determination of multiple markers. In this
technique, a laser beam with a specific wavelength is directed through a stream of a sheath fluid
containing the suspended particles. The presence of particles causes light scattering (Figure 2A).
In parallel, the studied particles are labeled with fluorescent dyes that can be either introduced to
their interior or immobilized on their surface, e.g., by monoclonal antibodies. Relying on the recorded
parameters, flow cytometry is able to analyze the relative size and granulation of the studied particles
alongside all other data that could be collected from the fluorescence staining, i.e., content of the
specific, fluorescently labeled, molecules. The detection of small particles on the basis of their light
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scattering signal is a major challenge for conventional flow cytometers [31]. This is mainly due
to the limited sensitivity and resolution of flow cytometers. Most of the current flow cytometers
can detect particles larger than 500 nm, few of them with improved parameters are able to detect
200 nm particles/beads [32]. Typically, the forward scattered light (0.5–5◦) can provide approximate
information about the size of particles [33]. EVs below 500 nm scatter laser light in the range of
electronic noise and sheath fluid alone, making it difficult to resolve particles in this size range using
forward scatter (FSC) thresholding [34,35]. Moreover, forward scatter is the most variable signal
between instruments of different manufacturers and its proper alignment is critical. It is affected by
the refractive index mismatches between the sheath fluid and the sample, beam geometry, polarization,
beam stop position and collection angle [36]. On the other hand, side-scattered light (15–150◦) is
often collected at the 90◦ angle and provides information about smaller particles or granularity of
internal structures. Thus, the side scatter (SSC) has been proposed as a trigger channel [36], as most
cytometers show a better detection sensitivity using SSC as a trigger rather than FSC for the analysis
of small particles [36,37]. Using SSC in this manner enables reproducing the sensitivity level of
190 nm latex particles [36], however, it can still lead to problems associated with EVs resolution
above the background noise [38]. A newer generation of flow cytometers uses multiple angles for
FSC detection, which results in better resolution of particles [32,35]. An alternative flow cytometry
approach has already been applied for the detection of EVs. It consists of triggering EVs detection on
a fluorescence parameter instead of light scattering to increase the separation of the EVs signals from
the background [38–40]. While this does help resolve the EVs from the electronic noise, it requires the
use of a fluorescent marker for all EVs, e.g., a lipophilic dye such as PKH26 [19].
In addition to the fact that a significant number of particles remain undetected due to the size
detection limitation of conventional flow cytometers, another problem arises when high concentrations
of EVs are being analyzed, which may result in the identification of multiple vesicles as a single event.
This phenomenon has been described as the “swarming” effect [41]. The underlying reason for this is
the fact that multiple vesicles illuminated simultaneously by the laser beam are necessary to generate
a signal above the threshold. As a result many EVs are counted as a single event signal.
Another problem related to EVs analysis by flow cytometry regards the determination of their
diameter (size). Usually, the information on the EVs diameter is obtained by comparing their scatter
parameters with those for the standard particles (e.g., polystyrene beads) of a known diameter that are
added to the sample. It should be, however, noted that the intensity of FSC is not related directly to the
particle size [33]. Also, one has to keep in mind that light scattering depends not only on the particle
diameter but also on the refractive index, absorption coefficient, and particle shape properties. Thus,
the properties of polystyrene beads significantly differ from those of cells (and therefore the EVs) [42].
Due to their low refractive index, lipid based vesicles scatter much less light than polystyrene beads.
As a consequence, the determination of EVs diameter in relation to polystyrene beads can be burdened
by substantial uncertainty.
Figure 2. Cont.
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Figure 2. (A) The principal of flow cytometry; (B) An exemplary analysis of microvesicles (MVs)
derived from HPC-4 cell line. Morphology of MVs according to forward scatter/side scatter (FSC/SSC)
(left) and surface expression of Her-2/neu antigen detected by fluorochrome (phycoerithrin-PE)
conjugated antibody (right). Plots from FACSCanto flow cytometer (BD Biosciences, San Jose,
CA, USA).
Despite the mentioned limitations of flow cytometry, this technique possesses unquestionable
advantages when applied in EVs analysis. One of them is high throughput, enabling fast measurements
of EVs suspended in a fluid. Additionally, if the EVs bear some antigens at their surface, it is possible
to detect them by applying fluorochrome-conjugated monoclonal antibodies. As a result, the vesicles
population studied can be quantified and/or classified according to the level of antigen expression
(Figure 2B) [43]. Flow cytometry can also be used to enumerate EVs by adding, as an internal standard,
a known number of fluorescent latex beads (Flow-Count Fluorospheres, Beckmann-Coulter, Brea, CA,
USA) or using tubes containing already predefined bead numbers (TruCount tubes, BD Biosciences,
San Jose, CA, USA) [37]. For smaller particles, such as exosomes (<100 nm in diameter) some other
approaches can be introduced to allow their analysis by flow cytometry. These usually involve the
use of latex beads coated with monoclonal antibodies, which can bind and “pull-out” EVs expressing
certain determinants. Such modification allows the detection of exosomes that were previously
“invisible” for flow cytometry [44].
A related technique, based on the Wallace Coulter principle [45] is termed impedance-based flow
cytometry. In this system, vesicles in electrolyte solution flow through a very narrow channel -aperture
(sensing zone), where each particle displaces its own volume of electrolyte. The displaced volume
increases the impedance, generating a voltage pulse where the height of each pulse is proportional
to the volume of the particle. In comparison to conventional flow cytometry, this technique is not
dependent on the refractive index of the particles tested. However, impedance-based flow cytometry
is able to resolve only EVs that are larger than 300 nm [46,47].
Recently, a relatively new flow cytometry-based method called imaging flow cytometry was
shown to allow the analysis of EVs smaller than 300 nm [48,49]. This technology combines the
capabilities of conventional flow cytometry with high resolution imaging at the single-cell level.
By adding imaging to flow cytometry, EVs can be clearly distinguished from beads, cellular debris
and/or parental cells. Moreover, in comparison to conventional flow cytometry, imaging flow
cytometry has a higher level of sensitivity for fluorescence detection of smaller particles [50].
In addition, algorithms have been developed to differentiate between aggregates and true EVs [49],
enabling more precise interpretation of the data.
2.1. Dynamic Light Scattering
Dynamic light scattering (DLS), also known as photon correlation spectroscopy, is another
technique which depends on the scattering of a laser beam. In this technique, a monochromatic
and coherent laser beam passes through a suspension of particles (Figure 3A). If a particle happens
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to be in the beam’s way, the laser light is dispersed and scattered in all directions. By recording the
intensity of the scattered light as a function of time, its fluctuations can be observed due to Brownian
motion of suspended particles.
Figure 3. (A) The principle of the dynamic light scattering; (B,C) Exemplary spectra of dynamic light
scattering (DLS) measurements of EVs present in human plasma of gastric cancer patient: (B) The most
numerous EVs population in the sample; (C) EVs size distribution.
During Brownian fluctuations, the distance between scattered light beams constantly changes with
time, leading to their interference, visible as minima (destructive interference) or maxima (enhanced
interference) in the recorded spectrum. To obtain a distribution of particle size, the autocorrelation
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function of the intensity spectra is generated, that is further used for size determination. The analysis
is relatively easy when suspended particles do not interfere with each other through collisions or
electrostatic forces. Figure 3B,C shows the exemplary size distributions of EVs obtained using the
DLS technique. The sample represents blood plasma collected from patients with gastric cancer (data
were collected using Zetasizer Nano ZS apparatus, Malvern Instruments, Malvern, UK). The range
of EVs size in the sample showed 2-mode distribution of approximately 80–110 and 800–1100 nm.
The most numerous particle population had the size of around 80 nm. In the analyzed sample, the size
distribution of EVs was dispersed indicating highly heterogeneous EVs population.
The biggest advantage of the DLS method is its ability to measure particles ranging from 1 nm
to 6 µm. It should be stressed out, however, that DLS delivers reliable data only when one type of
particles is present in the suspension (monodispersed suspensions). The method is less accurate in
suspensions of particles varying in size (polydispersed suspensions). In such cases, the obtained
profile of particle size is strongly influenced by larger particles, since they scatter more light. Therefore,
when larger vesicles are present in the suspension, even in a low quantity, the detection of smaller
events becomes problematic [51–53]. This implies the necessity to deplete the suspension that is being
analyzed from any large contaminates. The DLS technique has been demonstrated to be a tool for
assessing the distribution and size of EVs in the studies of red blood cell-derived procoagulant EVs [54]
or EVs derived from ovarian cancer cells [55]. The results obtained clearly state that the DLS technique
can provide the diameter range of analyzed vesicles, however, it is unable to deliver any biochemical
data or information about cellular origin of EVs [55].
2.2. Nanoparticle Tracking Analysis
Nanoparticle tracking analysis (NTA), like DLS, is a technique based on the ability to track the
Brownian motion of particles in suspension. The basic data about the processed particles that can
be acquired by this method include average size, modal value and size distribution. The typical
NTA device is composed of a laser module, a microscope connected to a sensitive charge-coupled
device (CCD) or complementary metal–oxide–semiconductor (CMOS) camera, a hydraulic pump
and a measuring chamber. It should be also pointed out that the measuring conditions (temperature
and viscosity) should be appropriately specified in the NTA software before the actual measurement.
The scheme of the NTA technique is presented in Figure 4A. The hydraulic pump puts particles present
in a sample suspension into motion by injecting them into the measuring chamber at a fixed flow rate
and exposing to a narrow laser beam (Figure 4B). Next, the movement of the illuminated particles
over a certain time period is being recorded by a highly sensitive camera installed onto an optical
microscope. From the acquired video recording, the displacement of each particle is tracked and
plotted as a function of time which enables the calculation of particle size distribution by applying the
two-dimensional Stokes-Einstein equation (Figure 4C).
Figure 4. Cont.
Int. J. Mol. Sci. 2017, 18, 1153 8 of 18
Figure 4. (A) A graphic representation of the nanoparticle tracking analysis (NTA) principle;
(B) An image of EVs secreted by tumors cells of the gastric cancer cell line GC1401 acquired by
the NTA system; (C) The corresponding EVs size distribution.
The non-symmetric character of the size distribution data observed in Figure 4C strongly indicates
that the studied suspension contains a heterogeneous population of particles, predominantly MVs
(EV > 100 nm).
The use of the NTA system to detect different EVs, including exosomes, has several advantages.
The first one is the ability to precisely measure small particles which diameter is as low as 30 nm.
Sample acquisition is performed in a liquid phase ensuring that there are no changes to the studied
EVs. Additionally, the sample preparation is very fast and easy, and the measurement itself takes
only minutes. Moreover, samples can be recovered in their native form after the measurements are
performed which makes this technique even more attractive.
If required, fluorescence can be also detected by the NTA system. This feature can be used
for the detection of antigens present on EVs by applying fluorescently labeled antibodies. Again,
the possibility of examining antigen composition as well as size distribution in smaller EVs, such as
exosomes, makes this method even more appealing since other methods do not have this capability.
This may be particularly important when monitoring phenotype changes in EVs present in certain
diseases [56–58].
Alongside advantages, the NTA technique has also some limitations. One of them is a proper
dilution of the sample for measurement purposes, which can be problematic especially if the sample
volume is limited. The main obstacle here is to find the “right” dilution factor so that the NTA camera
can register all the vesicles present in a sample and that there is no overlaying effect of a larger vesicle
masking a smaller one. As with other methods based on the Brownian motion principle, the masking
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of smaller vesicles by larger ones, obviously, can obscure the results making them unreliable [59].
The suggested optimal particle concentration for NTA measurements is in the range of 2 × 108 to
20 × 108/mL [60].
Another NTA limitation concerns the detection of a fluorescent signal. Although the NTA
system is capable of detecting fluorescence, its practical use for EV phenotyping is somewhat limited.
Our own and others’ experience suggests that the fluorescent signal needs to be very bright in
order to be detected by the NTA system in its current version [61,62]. Although fluorescent labeling
with dyes (e.g., PKH27, PKH67, etc.), which incorporate into the EVs membrane, seems to be
adequate for particle detection and their size/size distribution measurements, this approach does
not address EVs phenotyping. On the other hand, using directly labeled fluorescent monoclonal
antibodies for EVs antigen recognition by the NTA system had little success so far, especially in the
case of exosomes, unless the expression of the studied marker is high (e.g., CD63) [61]. It should
also be stressed that relying on fluorescence intensity as a quantification parameter may result in
inadequate data acquisition. This is due to the fact that the particles move in and out of focus and
the antibody flourochromes are susceptible to photobleaching. One promising alternative to solve
this problem involves the use of antibodies conjugated with quantum dots (Q-dots), which are very
bright fluorochromes. There are several studies reporting a successful application of Q-dot conjugated
antibodies for EVs phenotyping, however, the use of these antibodies is hampered by high background
coming from unbound Q-dots, which can alter the final measurements [61]. Thus, the use of fluorescent
NTA for EVs phenotyping, although promising, should be treated with caution.
2.3. Electron Microscopy
Electron microscopy (EM) is a technique which is widely used to characterize and visualize various
biological samples. It uses a beam of electrons to create an image of the studied sample. An electron
beam passes through the sample where a secondary electron is generated. These electrons are collected
and magnified using special lenses. In studies of biological samples, two types of EM are widely used,
namely, transmission electron microscopy (TEM) and cryo-electron microscopy (cryo-EM).
In TEM, an image is created by electron interference when the electron beam crosses the sample.
Since the wavelength of the electron beam is shorter than the wavelength of visible light by three
orders of magnitude, the images are recorded with resolution of 1 nm [63]. Moreover, immuno-gold
labeling opens the possibility of collecting biochemical information [64]. Unfortunately, benefits from
high resolution can be easily outweighed by disadvantages related to the measurement conditions
and sample preparation. The specimens analyzed by TEM have to be fixed and dehydrated before
the measurement. Additionally, the image acquisition is carried out under vacuum conditions.
Nonetheless, electron microscopy is utilized for EVs visualization and the obtained images are then
used for diameter determination of the studied vesicles. An example of a TEM image representing a
heterogeneous population of EVs isolated from the plasma of a gastric cancer patient is presented in
Figure 5.
The extensive and multistep preparations needed for electron microscopy can easily induce
changes in the morphology of the EVs. It has been reported by several studies that exosomes are
spherical, however, other EVs are heterogeneous in shape [15]. Moreover, in some cases, the electron
beam may also cause damages to biological samples. To counter these problems cryo-EM is being
applied for EVs analysis, which introduces a different protocol for sample preparation. In this method,
the specimen is kept and studied on vitreous ice at the temperature of liquid nitrogen, thus, the invasive
steps such as dehydration or fixation are being omitted [63,65,66]. This avoids ultra-structural changes
and redistribution of elements. Additionally, specimens are protected from damage caused by the
electron beam’s radiation through the application of very low temperature. Due to inelastic scattering,
images obtained with low-dosing techniques generate high background noise. It is possible to increase
signal-to-noise ratio and retrieve higher resolution by using computer methods of single particle
analysis [67]. Thus, studying biological samples with resolution lower than 1 nm is possible. Alongside
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two-dimensional (2-D) imaging it is also possible to generate 3-D images of specimen referred often to
cryo-Electron Tomography [68]. Such 3-D imaging helped to verify spherical rather than cup-shaped
morphology of exosomes, which was previously postulated based on TEM images. Furthermore,
this technique allows the analysis of EVs interior. Coleman et al. has reported that exosomes are
composed of more than one membrane which was confirmed by raw 2-D images as well by 3-D
cryo-electron tomography [69]. As in TEM, immuno-gold staining and measurements over time can
also be performed using this technique [70].
Figure 5. A graphic illustration of transmission electron microscopy (TEM) (A) and cryo-TEM (B)
principles; TEM image of extracellular vesicles collected from plasma of gastric cancer patients (C).
2.4. Atomic Force Microscopy
Atomic force microscopy (AFM) is a technique, which detects and records interactions between
the probing tip and the sample surface. The surface is probed by a delicate flat spring (called cantilever)
with a sharp tip mounted at its free end. When the tip is brought very close to the sample, the
interaction of forces leads to a deflection of the cantilever which is then recorded by the detection
system comprised of a laser and a position sensitive detector (a photodiode). Figure 6A illustrates the
schematic principle of AFM, while Figure 6B shows the results of EVs measurements by this technique.
Figure 6. Cont.
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Figure 6. (A) Schematic illustration of atomic force microscopy; (B) The size distribution of EVs derived
from HPC-4 cell line, obtained by the analysis of scanned topography image (inset).
An important feature of the AFM technique includes its ability to measure samples in their native
conditions with minimized sample preparation [71–73]. For example, Figure 6B illustrates the AFM
measurements of EVs obtained from HPC-4 cell lines. As required by the AFM technique, the EVs had
to be first immobilized on a freshly cleaved mica surface and then scanned. The recorded topography
image (Figure 6B) showed very broad distribution of the EVs. To calculate their diameter, the built-in
algorithm for grain analysis was applied.
The AFM allows to obtain a real 3-D image of surface topography recorded with very high
resolution, however, in order for the imaging to be successful, all vesicles must be attached to atomically
flat surface such as mica. It should be mentioned that EVs can change their shape and become flattened
after binding to mica surface. This can be overcome by functionalization of mica surface with molecules
that can both bind to EVs and at the same time preserve the measurement conditions. Moreover, EVs
bound to the surface by specific monoclonal antibodies can be used to gather quantitative information
on their specific interaction with the substrate surface [72,74]. Using such an approach, it is possible to
detect the presence of specific proteins with better resolution than immunogold labeling [75].
2.5. Other Methods
Apart of the aforementioned techniques used to characterize EVs, there are also other methods
that are not utilized so frequently in such studies. These include Raman spectroscopy, resistive
pulse sensing, fluorescence correlation spectroscopy, pulse laser activated cell sorter (PLACS), X-ray
microscopy, stimulated emission depletion microscopy (STED) or enzyme-linked immunosorbent
assays. Raman spectroscopy belongs to a group of light scattering techniques, it detects inelastic
scattered light that allows interrogation and identification of vibrational states of sample molecules.
As a result, it provides molecular fingerprints of the samples studied and enables monitoring of
changes that occur in the molecular bond structures. Based on such measurements, the chemical
composition of single EVs can be obtained [76]. Another approach uses tunable resistive pulse sensing
(TRPS), which is an impedance based method (Coulter principle). In this system a voltage is applied
across a size tunable nanopore filled with electrolyte, resulting in an ionic current. While passing
through the pore, the particles’ resistance increases, which in turn generates a pulse that is directly
proportional to the particles’ volume (www.izon.com). TRPS is used to characterize physical properties
of EVs, e.g., absolute size, concentration and surface charge (ζ potential) [77]. This method eliminates
limitation of an ensemble technique with intensity-weighted skewing such as DLS [78]. On the other
hand, fluorescence correlation spectroscopy (FCS) is an alternative technique to DLS, that uses the
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analysis of fluorescence intensity fluctuations for size determination of fluorescent particles. The main
advantage of FCS over DLS is its capability to detect a single, fluorescently labeled molecule. This
feature drives the detection limit under 50 nm, and is less prone to erroneous results in the presence
of larger particles [79,80]. Recently, Wyss et al. in an elegant study showed for the first time that
this technique can be used to determine not only the average parameters such as concentration and
size of the particles, but also, the number of bound antibodies (anti-CD63) per individual EVs, which
corresponds to the relative expression level of a particular membrane receptor [81].
Recently, further development of existing flow cytometers resulted in pulse laser activated cell
sorter (PLACS) microfluidics devices [82], enabling sorting by high speed fluid jets of individual EVs
with desired fluorescence properties at the rate of ~30,000/s. These fluid jets are generated by picoliter
bubbles (<100 picoliters), that are triggered by pulsed laser-induced cavitation [83] to help to eliminate
swarming phenomenon.
X-ray microscopy is a relatively new imaging modality also known as micro-computed
tomography (micro-CT), which can analyze samples at a resolution between that of the optical
microscope and the electron microscopy. The high resolution of X-ray microscopy is achieved
by reducing its wavelength to a few nm (shorter wavelength lowers the diffraction limit). X-rays
experience far less scattering within samples of all types which allows thicker samples to be imaged.
In the case of EVs, X-ray microscopy is a promising method for detecting the size and morphology of
vesicles in their physiological state [84,85].
Stimulated emission depletion microcopy (STED) is a method that delivers high resolution images
by selectively deactivating fluorophores. In this technique, the laser, tuned to the absorption spectrum
of the fluorescent dye, excites the molecule into the upper electronic state. Following this first pulse
an immediate second one is applied, which is red-shifted in the frequency to the emission spectrum
of the dye. Such a shift in photon energy causes quenching of excited dye molecules. Whereas the
first pulse is focused on the sample, the second pulse is arranged in a doughnut mode. This leads
to full quenching of molecules that are present at the periphery of the doughnut. The center part
remains unaffected by quenching, which leads to the increase in resolution. In this way, the STED
process enables us to obtain a resolution beyond the diffraction limit [86]. The typical resolution limit
for this method is around 50 nm, however, few groups reported resolution of about 10 nm [87,88].
Such measurements provide information on vesicles’ size and distribution of fluorescently labeled
antigens, present at the surface of EVs [89,90].
The widely used enzyme-linked immunosorbent assays (ELISA) can be modified for the detection
of EVs, especially exosomes. The kits usually consist of ELISA plates pre-coated with proprietary
pan-exosome antibodies that capture exosomes from different biological samples, including cell culture
supernatants and human biological fluids. Quantification and characterization of exosomal proteins is
subsequently performed using appropriate detection antibodies against exosome-associated antigens
whether generic or cell/tissue-specific. These kits contain also lyophilized exosomes as standards for
assay calibration [91].
Very recently, Yoshioka et al. described an ultra-sensitive method, called ExoScreen, for the
detection of tumor-derived exosomes in colorectal cancer patients’ serum without a purification
step [92]. The method is based on an amplified luminescent proximity homogeneous assay that uses
photosensitizer beads, and utilizes streptavidin-coated donor beads to capture pan-exosome specific
biotinylated antibody, e.g., anti-CD63 and acceptor beads conjugated to a secondary antibody that
recognizes a tissue/cell specific epitope of the exosomes. The donor beads, loaded with phtalocyanine,
are excited with a laser at 680 nm, converting endogenous diatomic oxygen to singlet oxygen, which
excites an amplified fluorescent signal in the acceptor beads (thioxene-loaded). As a result, the acceptor
beads emit light at 615 nm, detected by the luminescence plate reader. The emission occurs only if
acceptor beads are within ~200 nm of donor ones, eliminating the signal coming from larger vesicles
as well as from soluble proteins. By this approach, the authors were able to detect tumor-derived
exosomes in a volume as low as 5 µL of patient’s plasma [92].
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3. Summary
With increasing interest in EVs as conveyors of many vital signals under either normal or
pathological conditions, new methods are being developed, or the current ones adapted, towards
reliable and fast characterization of EVs properties. Recent studies have provided information about
a large variety of EVs secreted by cells in response to their state [93,94]. This is particularly important
in the case of various diseases, including cancer. Depending on the interest, whether diagnostic or
scientific, present and future techniques should aim at a reliable and precise EVs data acquisition.
Although the current EVs analysis methods are unable to simultaneously and completely assess all
the key EVs parameters (i.e., size, phenotype, morphology, etc.), they are, individually, capable of
obtaining all the necessary information; with limitations.
Thus, for relatively cheap and fast acquisition of EVs phenotype, methods such as flow cytometry
or Coulter’s counter should be applied. In certain cases, additional information related to the particles’
size and number can be acquired by these methods. Research, demanding more precise information
on size distribution or concentration should involve more sophisticated methods such as DLS or
NTA. These methods seem to be capable of multiparameter data analysis that can translate into better
understanding of all EVs. Obtaining highly specific data on EVs morphology may be accomplished
by electron and/or atomic force microscopies, which enable the analysis of structural and biological
characteristics of EVs. A more rigorous EVs characterization (i.e., microRNA, lipid and protein
analysis), however, requires the application of a combination of the above methods with the addition of
the “omics” technology. With the advancement of technology in sight, the EVs analysis field has a lot of
room for improvement which could unlock the full potential of EVs driven cell-to-cell communication.
Acknowledgments: This work was supported by National Science Centre; grant number: UMO-2012/07B/
NZ6/03499. The DLS data was obtained as a result of a cooperation with Maria Zembala (Institute of Catalysis
and Surface Chemistry, Polish Academy of Sciences).
Author Contributions: All authors contributed to the manuscript. Jarek Baran and Monika Baj-Krzyworzeka
designed the concept of the review, Rafał Szatanek prepared the final version of the manuscript, Jakub Zimoch
wrote draft version of the paper, Małgorzata Lekka improved the physical aspects of the methods, and
Maciej Siedlar critically read the manuscript.
Conflicts of Interest: The authors declare no conflict of interest.
Abbreviations
AFM Atomic force microscopy
DLS Dynamic light scattering
ELISA Enzyme-linked immunosorbent assay
EV Extracellular vesicle




NTA Nanoparticle tracking analysis
SSC Side scatter
STED Stimulated emission depletion microscopy
TEM Transmission electron microscopy
References
1. Zomer, A.; Vendrig, T.; Hopmans, E.S.; van Eijndhoven, M.; Middeldorp, J.M.; Pegtel, D.M. Exosomes.
Commun. Integr. Biol. 2010, 3, 447–450. [CrossRef] [PubMed]
2. Valadi, H.; Ekström, K.; Bossios, A.; Sjöstrand, M.; Lee, J.J.; Lötvall, J.O. Exosome-mediated transfer of
mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9,
654–659. [CrossRef] [PubMed]
Int. J. Mol. Sci. 2017, 18, 1153 14 of 18
3. Simpson, R.J.; Jensen, S.S.; Lim, J.W.E. Proteomic profiling of exosomes: Current perspectives. Proteomics
2008, 8, 4083–4099. [CrossRef] [PubMed]
4. Subra, C.; Laulagnier, K.; Perret, B.; Record, M. Exosome lipidomics unravels lipid sorting at the level of
multivesicular bodies. Biochimie 2007, 89, 205–212. [CrossRef] [PubMed]
5. Théry, C.; Zitvogel, L.; Amigorena, S. Exosomes: Composition, biogenesis and function. Nat. Rev. Immunol.
2002, 2, 569–579. [PubMed]
6. Heijnen, H.F.; Schiel, A.E.; Fijnheer, R.; Geuze, H.J.; Sixma, J.J. Activated platelets release two types
of membrane vesicles: Microvesicles by surface shedding and exosomes derived from exocytosis of
multivesicular bodies and α-granules. Blood 1999, 94, 3791–3799. [PubMed]
7. Mitchell, P.S.; Parkin, R.K.; Kroh, E.M.; Fritz, B.R.; Wyman, S.K.; Pogosova-Agadjanyan, E.L.; Peterson, A.;
Noteboom, J.; O’Briant, K.C.; Allen, A.; et al. Circulating microRNAs as stable blood-based markers for
cancer detection. Proc. Natl. Acad. Sci. USA 2008, 105, 10513–10518. [CrossRef] [PubMed]
8. Rabinowits, G.; Gerçel-Taylor, C.; Day, J.M.; Taylor, D.D.; Kloecker, G.H. Exosomal microRNA: A diagnostic
marker for lung cancer. Clin. Lung Cancer 2009, 10, 42–46. [CrossRef] [PubMed]
9. Yáñez-Mó, M.; Siljander, P.R.-M.; Andreu, Z.; Zavec, A.B.; Borràs, F.E.; Buzas, E.I.; Buzas, K.; Casal, E.;
Cappello, F.; Carvalho, J.; et al. Biological properties of extracellular vesicles and their physiological
functions. J. Extracell. Vesicles 2015, 4, 27066. [CrossRef] [PubMed]
10. Ratajczak, J.; Wysoczynski, M.; Hayek, F.; Janowska-Wieczorek, A.; Ratajczak, M.Z. Membrane-derived
microvesicles: Important and underappreciated mediators of cell-to-cell communication. Leukemia 2006, 20,
1487–1495. [CrossRef] [PubMed]
11. Schorey, J.S.; Bhatnagar, S. Exosome function: From tumor immunology to pathogen biology. Traffic 2008, 9,
871–881. [CrossRef] [PubMed]
12. Piccin, A.; Murphy, W.G.; Smith, O.P. Circulating microparticles: Pathophysiology and clinical implications.
Blood Rev. 2007, 21, 157–171. [CrossRef] [PubMed]
13. Trajkovic, K.; Hsu, C.; Chiantia, S.; Rajendran, L.; Wenzel, D.; Wieland, F.; Schwille, P.; Brügger, B.; Simons, M.
Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 2008, 319, 1244–1247.
[CrossRef] [PubMed]
14. Wubbolts, R.; Leckie, R.S.; Veenhuizen, P.T.M.; Schwarzmann, G.; Möbius, W.; Hoernschemeyer, J.; Slot, J.W.;
Geuze, H.J.; Stoorvogel, W. Proteomic and biochemical analyses of human B cell-derived exosomes: Potential
implications for their function and multivesicular body formation. J. Biol. Chem. 2003, 278, 10963–10972.
[CrossRef] [PubMed]
15. Colombo, M.; Raposo, G.; Théry, C. Biogenesis, secretion, and intercellular interactions of exosomes and
other extracellular Vesicles. Annu. Rev. Cell Dev. Biol. 2014, 30, 255–289. [CrossRef] [PubMed]
16. Théry, C.; Ostrowski, M.; Segura, E. Membrane vesicles as conveyors of immune responses.
Nat. Rev. Immunol. 2009, 9, 581–593. [CrossRef] [PubMed]
17. Cocucci, E.; Racchetti, G.; Meldolesi, J. Shedding microvesicles: Artefacts no more. Trends Cell Biol. 2009, 19,
43–51. [CrossRef] [PubMed]
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